Transitioning psoriasis patients to adalimumab following a suboptimal response to etanercept, methotrexate, or phototherapy: efficacy and safety results from an open-label study

被引：0

作者：

Strober, B. ^{[1
]}

Poulin, Y. ^{[2
]}

Kerdel, F. ^{[3
]}

Langley, R. ^{[4
]}

Menter, A. ^{[5
]}

Papp, K. ^{[6
]}

Gu, Y. ^{[7
]}

Okun, M. ^{[7
]}

机构：

[1] NYU, Sch Med, New York, NY USA

[2] Ctr Dermatol Quebec Metropolitain, Quebec City, PQ, Canada

[3] Florida Acad Dermatol Ctr, Miami, FL USA

[4] Dalhousie Univ, Halifax, NS, Canada

[5] Baylor Psoriasis Res Inst, Dallas, TX USA

[6] Clin Res, Waterloo, ON, Canada

[7] Abbott Labs, Abbott Pk, IL 60064 USA

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2010年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P021

引用

页码：9 / 9

页数：1

共 50 条

[1] Transitioning psoriasis patients to adalimumab following a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study
Strober, Bruce
Okun, Martin
Gu, Yihua
Poulin, Yves
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB124 - AB124
[2] Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study
Strober, Bruce E.
Poulin, Yves
Kerdel, Francisco A.
Langley, Richard G.
Gu, Yihua
Gupta, Shiraz R.
Okun, Martin M.
Papp, Kim A.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (04) : 671 - 681
[3] Adalimumab treatment of psoriasis patients following suboptimal responses to etanercept, methotrexate, or phototherapy: Efficacy across subgroups in an open-label study
Strober, B.
Goldblum, O.
Langley, R.
Gu, Y.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB152 - AB152
[4] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
Leonardi, Craig
Strober, Bruce
Gottlieb, Alice B.
Elewski, Boni E.
Ortonne, Jean-Paul
van de Kerkhof, Peter
Chiou, Chiun-Fang
Dunn, Meleana
Jahreis, Angelika
JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
[5] Adalimumab provides health-related quality of life benefits for patients with psoriasis with suboptimal response to etanercept, methotrexate, or phototherapy
Duffin, Kristina
Menter, Alan
Yang, Hongbo
Gupta, Shiraz
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB155 - AB155
[6] The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study
Gottlieb, Alice B.
Kalb, Robert E.
Blauvelt, Andrew
Heffernan, Michael P.
Sofen, Howard L.
Ferris, Laura Korb
Kerdel, Francisco A.
Calabro, Stephen
Wang, Jim
Kerkmann, Urs
Chevrier, Marc
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (04) : 642 - 650
[7] Methotrexate-treated psoriasis patients transitioning to adalimumab: Efficacy and safety outcomes
Mrowietz, Ulrich
Go, Yihua
Okun, Martin
Luger, Thomas
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB120 - AB120
[8] Efficacy and safety of briakinumab for treatment of moderate to severe psoriasis in patients previously receiving etanercept: Results from an open-label extension
Strober, Bruce
Leonardi, Craig
Williams, David A.
Olds, Michele
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB191 - AB191
[9] Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study
Leonardi, C.
Sobell, J. M.
Crowley, J. J.
Mrowietz, U.
Bao, Y.
Mulani, P. M.
Gu, Y.
Okun, M. M.
BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (03) : 658 - 667
[10] Adalimumab effects on C-reactive protein and sleep in patients with moderate to severe psoriasis and suboptimal response to etanercept, methotrexate, or phototherapy: Subanalysis of the PROGRESS study
Poulin, Y.
Wang, Y.
Goldblum, O.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S160 - S160

← 1 2 3 4 5 →